Many of our patients have indicated they are planning a vacation over the winter months to a sunny destination. It…
Publicly funded shingles vaccination has been available for many years for adults aged 65-70. Initially, the vaccine provided was Zostavax,…
Happy New Year to our Charlton Family! We enter 2023 with much excitement as treatments for autoimmune diseases continue to…
As we near the end of 2022, we thought we would share some of our most popular blog posts of…
According to Health Canada’s guidance on fall prevention, falls are the leading cause of injury among older Canadians. In fact,…
On October 20, 2022, Health Canada granted approval for SKYRIZI® (risankizumab) as the latest addition for the treatment of moderate-severe Crohn’s disease.…
We have had many calls asking about the timing of vaccines this fall. As clinical pharmacists working at Charlton Health,…
Atopic Dermatitis is commonly referred to as eczema. The foundation of the condition is skin barrier dysfunction, whereby allergens and…
Health Canada has approved Evusheld as a preventative treatment for COVID-19. It is not intended to replace COVID-19 vaccinations, but…
At Charlton Health, a center specializing in advanced treatments including biologic therapies, we are often excited when additional treatment options…